• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Strain differences in brain alpha2- and beta-adrenergic receptor binding in dystrophic mice.

作者信息

Wilkinson M, Manchester E L

出版信息

Brain Res Bull. 1983 Dec;11(6):743-5. doi: 10.1016/0361-9230(83)90018-7.

DOI:10.1016/0361-9230(83)90018-7
PMID:6318921
Abstract

We have examined alpha 2-adrenergic [( 3H]-clonidine) and beta-adrenergic [( 3H]-dihydroalprenolol; DHA) binding in brain membranes from four different dystrophic mouse mutants: 129/ReJ-dy; 129 B6F1/J-dy; C57BL/6J-dy and C57BL/6J-dy2J. As shown previously, male 129/ReJ-dy mice have significantly fewer brain [3H]-DHA binding sites than their littermate controls. In marked contrast, the remaining three mutants showed no differences in [3H]-DHA binding when compared to their respective controls although there were inter-strain differences, e.g., C57BL/6J-dy2J mice have significantly fewer binding sites than the 129B6F1/J-dy mice. On the other hand, we saw no strain differences in alpha 2-binding. In one mutant, however, (129 B6F1/J-dy) we observed a 50% increase in alpha 2-binding sites compared to littermate controls. We conclude that weight loss or undernutrition may be an important factor in determining brain levels of adrenergic binding sites in dystrophic mouse brain.

摘要

相似文献

1
Strain differences in brain alpha2- and beta-adrenergic receptor binding in dystrophic mice.
Brain Res Bull. 1983 Dec;11(6):743-5. doi: 10.1016/0361-9230(83)90018-7.
2
beta-Adrenergic, but not benzodiazepine, binding sites are reduced in dystrophic mouse brain.在营养不良的小鼠大脑中,β-肾上腺素能结合位点减少,但苯二氮䓬结合位点未减少。
Brain Res Bull. 1982 May;8(5):547-9. doi: 10.1016/0361-9230(82)90014-4.
3
Modulation of alpha 1-and alpha 2-adrenoceptor binding sites in the brain of audiogenic seizure susceptible mice (DBA/2J).声源性癫痫易感小鼠(DBA/2J)大脑中α1和α2肾上腺素能受体结合位点的调节
Eur J Pharmacol. 1985 Dec 3;118(3):231-7. doi: 10.1016/0014-2999(85)90133-5.
4
Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.采用放射性配体结合分析法研究新型α、β肾上腺素能受体联合拮抗剂YM-09538对α和β肾上腺素能受体亚型的亲和力。
Arch Int Pharmacodyn Ther. 1983 Mar;262(1):34-46.
5
Altered postnatal ontogeny of alpha 1- and alpha 2-adrenoceptor binding sites in the brain of a convulsive mutant mouse (quaking).
Brain Res. 1985 Oct;354(2):229-35. doi: 10.1016/0165-3806(85)90174-9.
6
Adrenergic receptors on cerebral microvessels in control and parkinsonian subjects.对照和帕金森病患者大脑微血管上的肾上腺素能受体
Life Sci. 1985 Aug 12;37(6):531-6. doi: 10.1016/0024-3205(85)90465-5.
7
Displacement of alpha- and beta-radioligands by specific adrenergic agonists in rat pancreatic islets.大鼠胰岛中特异性肾上腺素能激动剂对α和β放射性配体的置换作用。
Pharmacology. 1983;27(2):95-102. doi: 10.1159/000137840.
8
Hippocampal alpha- and beta-adrenergic receptors: comparison of [3H]dihydroalprenolol and [3H]WB 4101 binding with noradrenergic innervation in the rat.海马α-和β-肾上腺素能受体:大鼠中[3H]二氢阿普洛尔和[3H]WB 4101结合与去甲肾上腺素能神经支配的比较。
Brain Res. 1980 Jan 20;182(1):107-17. doi: 10.1016/0006-8993(80)90834-3.
9
Adrenergic receptors in frontal cortex in human brain.人类大脑额叶皮质中的肾上腺素能受体。
Eur J Pharmacol. 1985 Feb 5;108(3):225-32. doi: 10.1016/0014-2999(85)90444-3.
10
Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.人肝细胞膜中的肾上腺素能受体:β2和α1受体亚型占主导地位。
J Clin Endocrinol Metab. 1986 May;62(5):827-32. doi: 10.1210/jcem-62-5-827.

引用本文的文献

1
Incorporating inter-individual variability in experimental design improves the quality of results of animal experiments.在实验设计中纳入个体间变异性可提高动物实验结果的质量。
PLoS One. 2021 Aug 5;16(8):e0255521. doi: 10.1371/journal.pone.0255521. eCollection 2021.